Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
Titomic ASX Shares in Focus After New Semiconductor Production Contract
Source: Kapitales Research
Highlights
Titomic has moved from low-rate production into full-rate manufacturing for a semiconductor customer.
The program is expected to generate about AU$1.5 million in 2027 and could rise to around AU$3.2 million in 2028.
The contract supports Titomic’s strategy of building recurring manufacturing revenue from its cold spray technology.
Titomic Moves Into Full-Rate Semiconductor Production
Titomic Limited (ASX: TTT) announced on 8 October 2026 that its wholly owned Netherlands subsidiary, Titomic Europe B.V., had secured a full-rate production contract in the semiconductor industry. The latest contract follows a successful low-rate initial production program awarded in 2025 and marks the customer’s move from early-stage production validation into ongoing manufacturing. Titomic shares were trading flat at AU$0.120.
The development is significant because it shows that Titomic has progressed beyond product and process validation into commercial-scale manufacturing for a demanding technology customer. The move also reflects growing confidence in the company’s ability to consistently deliver production-quality components using its proprietary Titomic Kinetic Fusion, or TKF, cold spray technology.
Revenue Contribution Expected to Increase
Based on the current production run rate, Titomic expects the semiconductor contract to generate approximately EUR 0.9 million, equivalent to AU$1.5 million, in 2027. The company indicated that revenue could increase to around EUR 2.0 million, or approximately AU$3.2 million, in 2028 depending on the customer’s future requirements.
The potential rise in revenue highlights the value of moving customers from qualification programs into ongoing production. Rather than relying only on equipment sales or development work, Titomic is seeking to establish a larger base of repeat manufacturing revenue. This contract provides a practical example of that strategy beginning to take shape.
TKF Technology Supports Commercial Expansion
Titomic’s TKF cold spray platform is used across production, coating and repair applications. The company serves several industrial markets, including aerospace, defense, shipbuilding, semiconductors, oil and gas, mining and automotive. It provides manufacturing services, original equipment production, research and development capabilities, cold spray systems and support services across its international operations.
Management said the transition from initial production to full-rate manufacturing reinforces the commercial potential of the TKF platform. Chief Executive Officer Jim Simpson also highlighted the company’s focus on converting customer development and qualification programs into recurring production work.
Outlook
The semiconductor contract gives Titomic an opportunity to demonstrate that its technology can support dependable production at commercial scale. Successful execution during 2027 could also help strengthen the company’s position when pursuing similar programs across other advanced manufacturing sectors.
Attention will now turn to whether customer demand increases enough to support the higher revenue potential outlined for 2028. Titomic’s longer-term growth will also depend on securing additional production contracts and converting more development programs into recurring revenue streams. If the company can repeat this progression across multiple customers, its manufacturing business could become a more meaningful contributor to future growth.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Titomic ASX Shares in Focus After New Semiconductor Production Contract
Highlights
Titomic Moves Into Full-Rate Semiconductor Production
Titomic Limited (ASX: TTT) announced on 8 October 2026 that its wholly owned Netherlands subsidiary, Titomic Europe B.V., had secured a full-rate production contract in the semiconductor industry. The latest contract follows a successful low-rate initial production program awarded in 2025 and marks the customer’s move from early-stage production validation into ongoing manufacturing. Titomic shares were trading flat at AU$0.120.
The development is significant because it shows that Titomic has progressed beyond product and process validation into commercial-scale manufacturing for a demanding technology customer. The move also reflects growing confidence in the company’s ability to consistently deliver production-quality components using its proprietary Titomic Kinetic Fusion, or TKF, cold spray technology.
Revenue Contribution Expected to Increase
Based on the current production run rate, Titomic expects the semiconductor contract to generate approximately EUR 0.9 million, equivalent to AU$1.5 million, in 2027. The company indicated that revenue could increase to around EUR 2.0 million, or approximately AU$3.2 million, in 2028 depending on the customer’s future requirements.
The potential rise in revenue highlights the value of moving customers from qualification programs into ongoing production. Rather than relying only on equipment sales or development work, Titomic is seeking to establish a larger base of repeat manufacturing revenue. This contract provides a practical example of that strategy beginning to take shape.
TKF Technology Supports Commercial Expansion
Titomic’s TKF cold spray platform is used across production, coating and repair applications. The company serves several industrial markets, including aerospace, defense, shipbuilding, semiconductors, oil and gas, mining and automotive. It provides manufacturing services, original equipment production, research and development capabilities, cold spray systems and support services across its international operations.
Management said the transition from initial production to full-rate manufacturing reinforces the commercial potential of the TKF platform. Chief Executive Officer Jim Simpson also highlighted the company’s focus on converting customer development and qualification programs into recurring production work.
Outlook
The semiconductor contract gives Titomic an opportunity to demonstrate that its technology can support dependable production at commercial scale. Successful execution during 2027 could also help strengthen the company’s position when pursuing similar programs across other advanced manufacturing sectors.
Attention will now turn to whether customer demand increases enough to support the higher revenue potential outlined for 2028. Titomic’s longer-term growth will also depend on securing additional production contracts and converting more development programs into recurring revenue streams. If the company can repeat this progression across multiple customers, its manufacturing business could become a more meaningful contributor to future growth.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au